skip to main content
Centre for Health Economics and Policy Analysis
Chris Longo

Christopher Longo
CV

Associate Professor, Health Policy and Management,
Executive committee member, Masters in Health Management Program (MHM), DeGroote School of Business,
Associate Professor, Health Policy and Management, DeGroote School of Business (Room 422, Ron Joyce Centre),
Member, Centre for Health Economics and Policy Analysis, McMaster University,
Co-Lead, Health Technology Assessment, Canadian Centre for Applied Research in Cancer Control

T: (905) 525-9140, ext. 23896
E: cjlongo@mcmaster.ca

McMaster University
Ron Joyce Centre, Rm 422
4350 South Service Road
Burlington, ON
L7L 5R8

Christopher Longo has more than 25 years of industry experience in clinical research, economic evaluation, and market access strategies for pharmaceuticals. He has published both clinical and economic research in a number of therapeutic areas including diabetes, cancer, sepsis and central nervous system disorders. His primary program of research investigates efficiency and equity issues in health care by using health economics tools to address policy questions. Much of this work has been in chronic and critical illness, and involves collaboration with researchers who have appropriate clinical expertise. He has undertaken research projects examining pharmaceutical innovation and pricing, and issues related to equity of access within this industry. His current research focus examines the costs and economic evaluation of cancer programs and interventions throughout the cancer journey, with the intent of informing policy decision-making. Longo has consulted with numerous provincial and federal agencies related to economic evaluation of pharmaceuticals including: the Canadian Agency for Drugs and Technology in Health, Cancer Care Ontario, Ontario Ministry of Health and Long Term Care and the National Cancer Institute of Canada. Longo is co-lead of the Health Technology Assessment Research Program at the Canadian Centre for Applied Research in Cancer Control and a former member of the Ontario Steering Committee for Cancer Drugs (OSCCD). He has undertaken reviews for the journals Pharacoeconomics, Medical Care, Canadian Medical Association Journal, Value in Health, Journal of Palliative Care, European Journal of Cancer Care and Supportive Care in Cancer.

RESEARCH INTERESTS

  • cost effectiveness, cost utility, and quality of life analysis in the areas of cancer, diabetes, and sepsis
  • evaluating strategies associated with global pharmaceutical pricing
  • understanding patients’ financial burden associated with health care, and the role of the state
  • understanding the factors that lead to higher individual consumption of health care resources

REPRESENTATIVE PUBLICATIONS

Schwartz R, Haja F, Babayan A, Longo CJ, Ferrence R. Public Health Policy in Support of Insurance Coverage for Smoking Cessation Treatment.
Healthcare Policy. 2017. 12(4): 56-68.

Martino R, Longo CJ, Ringash J, Durkin L, Greco E, Hui-Huang S, Xu W. Health Benefits and Incurred Costs from Early Dysphagia Intervention for Patients Receiving Chemoradiotherapy for Head and Neck Cancer: Pilot Study Findings. Current Oncology. 2-17. IN PRESS. 

Cheung K, Naur MN, Tolliver T, Longo CJ, Naam NH, Thoma A. A Tale of Two Health-Care Systems: Cost-Utility Analysis of Open Carpal Tunnel Release in Canada and the United States. Plastic Surgery. 2017, Vol. 25(1) 7-13.

Sekercioglu N, Thabane L, Diaz-Martinez JP, Nesrallah G, Longo CJ, Busse J.W, Akhtar-Danesh N, Agarwal A, Al-Khalifah R, Iorio A, Guyatt GH.Comparative effectiveness of phosphate binders in patients  with chronic kidney disease: A systematic review and network meta-analysis. PLoS ONE, 2016. 8;11(6).

 

Longo CJ, Fitch M, Grignon M, McAndrew A. Understanding the full breadth of cancer-related patient costs in Ontario: A qualitative exploration. Journal of Supportive Care Cancer. 2016. 24(11), 4541-4548

Longo, CJ. Cost-sharing for health care services:  An alternative strategy for pharmaceutical reimbursement in Ontario. Journal of Population Therapeutics and Clinical Pharmacology. 2015. 22(3):e245-e250

Di Rezze B, Nguyen T, Barr N, Mulvale G, Longo CJ,  Randall G. A scoping review of evaluated interventions addressing developmental transitions for youth with mental health disorders. Child Care Health and Development. 2015. DOI: 10.1111/cch.12306

Embrett M, Randall G, Longo CJ, Nguyen T, Mulvale G. Effectiveness of Health System Services and Programs for Youth to Adult Transitions in Mental Health Care: A Systematic Review of Academic Literature. Administration and Policy in Mental Health and Mental Health Services Research. DOI:10.1111/cch.12306

Lehoux P, Daudelin G, Williams-Jones B, Longo CJ. How do business model and health technology design influence each other? Insights from a longitudinal case study of three academic spin-offs. Research Policy. 2014. 43(6): 1025-1038.

Schlachta CM, Ashamalla S, Smith A. and members of the MIS in the Management of Colon and Rectal Cancer Consensus Group (including Longo, CJ.). MIS in the management of colon and rectal cancer: Consensus meeting of the Colorectal Cancer Association of Canada. Surgical Endoscopy. 2013. 27: 3981-3989.

Longo, CJ. Economic evaluation of a public health strategy: An examination of the human papillomavirus vaccine. International Journal of Behavioral and Healthcare Research. 2013. V4 (2): 158-168.

Hivon M, Lehoux P, Longo CJ, Williams-Jones, B, Miller FA. Building business relationships through the web: How medical technology companies enroll stakeholders in innovation development and uptake. International Review of Social Research. 2013. V3(2): 89-112.

Longo CJ, Grignon M. The value of fixed-reimbursement insurance against cancer related losses: simulations to investigate state-dependent utility. Global Business and Economics Review, in press February 2012.

Longo CJ, Bereza BG. A comparative analysis of monthly 'out-of-pocket' costs for breast cancer patients versus other common cancers in Ontario, Canada. Current Oncology. 2011. v18 (1): e1-e8.

Longo CJ. Encouraging pharmaceutical innovation to meet the needs of both developed and developing countries. International Journal of Development Issues. 2011v10(1): 92-101.

Longo CJ. Equitable access to healthcare services and income replacement for cancer: Is critical illness insurance a help or a hindrance? Healthcare Policy. 2010. 5(4): e132-e138.

Longo CJ. Global pharmaceutical pricing strategies: Profit implications of price discounting. International Journal of Economics and Business Research. 2010. V2 (6): 447-460.

Hopkins RB, Goeree R, Longo CJ. Estimating the National Wage Loss from Cancer in Canada. Current Oncology. 2010. 17(2): 40-49.

TEACHING ACTIVITIES

  • health economics and evaluation (MBA/HRM)
  • population health management (MBA)
  • tools and approaches for public health policy analysis and evaluation (Dalla Lana School of Public Health, U of T)
All people
Please send questions, comments or suggestions to the Webmaster (chepa@mcmaster.ca ).
Please review our Copyright Disclaimer policy

Interactive Marketing | Cubicle Fugitive